These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8821048)

  • 1. The antiparkinsonian drug budipine binds to NMDA and sigma receptors in postmortem human brain tissue.
    Kornhuber J; Herr B; Thome J; Riederer P
    J Neural Transm Suppl; 1995; 46():131-7. PubMed ID: 8821048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ibogaine on the various sites of the NMDA receptor complex and sigma binding sites in rat brain.
    Itzhak Y; Ali SF
    Ann N Y Acad Sci; 1998 May; 844():245-51. PubMed ID: 9668682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiparkinsonian drugs budipine and biperiden are use-dependent (uncompetitive) NMDA receptor antagonists.
    Jackisch R; Kruchen A; Sauermann W; Hertting G; Feuerstein TJ
    Eur J Pharmacol; 1994 Oct; 264(2):207-11. PubMed ID: 7851484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of the anabolic androgenic steroid nandrolone alters neurosteroid action at the sigma-1 receptor but not at the sigma-2 or NMDA receptors.
    Elfverson M; Johansson T; Zhou Q; Le Grevès P; Nyberg F
    Neuropharmacology; 2011 Dec; 61(7):1172-81. PubMed ID: 21251916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.
    Coughenour LL; Cordon JJ
    J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition.
    Whittemore ER; Ilyin VI; Woodward RM
    J Pharmacol Exp Ther; 1997 Jul; 282(1):326-38. PubMed ID: 9223571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
    Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
    J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halogenated 4-(phenoxymethyl)piperidines as potential radiolabeled probes for sigma-1 receptors: in vivo evaluation of [123I]-1-(iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]pip eri dine.
    Waterhouse RN; Mardon K; Giles KM; Collier TL; O'Brien JC
    J Med Chem; 1997 May; 40(11):1657-67. PubMed ID: 9171875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and binding affinities of methylvesamicol analogs for the acetylcholine transporter and sigma receptor.
    Shiba K; Ogawa K; Ishiwata K; Yajima K; Mori H
    Bioorg Med Chem; 2006 Apr; 14(8):2620-6. PubMed ID: 16434200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-evaluation of phencyclidine low-affinity or "non-NMDA" binding sites.
    Hirbec H; Mausset AL; Kamenka JM; Privat A; Vignon J
    J Neurosci Res; 2002 May; 68(3):305-14. PubMed ID: 12111860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the antiparkinsonian drug budipine on central neurotransmitter systems.
    Klockgether T; Wüllner U; Steinbach JP; Petersen V; Turski L; Löschmann PA
    Eur J Pharmacol; 1996 Apr; 301(1-3):67-73. PubMed ID: 8773448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by sigma receptor ligand, MS-377, of N-methyl- D-aspartate-induced currents in dopamine neurons of the rat ventral tegmental area.
    Yamazaki Y; Ishioka M; Matsubayashi H; Amano T; Sasa M
    Psychopharmacology (Berl); 2002 Apr; 161(1):64-9. PubMed ID: 11967632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantiomerically pure 1,3-dioxanes as highly selective NMDA and σ₁ receptor ligands.
    Köhler J; Bergander K; Fabian J; Schepmann D; Wünsch B
    J Med Chem; 2012 Oct; 55(20):8953-7. PubMed ID: 23013229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits.
    Coughenour LL; Barr BM
    J Pharmacol Exp Ther; 2001 Jan; 296(1):150-9. PubMed ID: 11123375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiparkinsonian agent budipine is an N-methyl-D-aspartate antagonist.
    Klockgether T; Jacobsen P; Löschmann PA; Turski L
    J Neural Transm Park Dis Dement Sect; 1993; 5(2):101-6. PubMed ID: 8333906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity of 1-aminoadamantanes for the sigma binding site in post-mortem human frontal cortex.
    Kornhuber J; Schoppmeyer K; Riederer P
    Neurosci Lett; 1993 Dec; 163(2):129-31. PubMed ID: 8309617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
    Biggs CS; Fisher A; Starr MS
    Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of dehydroepiandrosterone sulfate and allopregnanolone sulfate on the binding of [(3)H]ifenprodil to the N-methyl-d-aspartate receptor in rat frontal cortex membrane.
    Johansson T; Le Grevès P
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):263-6. PubMed ID: 15862974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of N-methyl-D-aspartate receptors by haloperidol: developmental and pharmacological characterization in native and recombinant receptors.
    Lynch DR; Gallagher MJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):154-61. PubMed ID: 8858988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino]cyclohexanol [(+)-pIV] as a sigma-1 receptor ligand.
    Shiba K; Ogawa K; Mori H
    Bioorg Med Chem; 2005 Feb; 13(4):1095-9. PubMed ID: 15670917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.